Unknown

Dataset Information

0

Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.


ABSTRACT: Bullous pemphigoid (BP) is an autoimmune blistering skin disease induced by pathogenic autoantibodies against a type II transmembrane protein (BP180, collagen type XVII, or BPAG2). In animal models, BP180 autoantibody-antigen interaction appears insufficient to develop blisters, but involvement of complement and neutrophils is required. However, cultured keratinocytes treated with BP-IgG exhibit a reduction in the adhesive strength and a loss of expression of BP180, suggesting that the autoantibodies directly affect epidermal cell-extracellular matrix integrity. In this study, we explored the consequences of two distinct epithelial cells treated with BP-IgG, particularly the fate of BP180. First, we followed the distribution of green fluorescent protein-tagged BP180 in an epithelial cell line, 804G, and normal human epidermal keratinocytes after autoantibody clustering. After BP-IgG treatment, the adhesive strength of the cells to their substrate was decreased, and BP180 was internalized in both cell types, together with the early endosomal antigen-1. By using various endocytosis inhibitors and a fluid-uptake assay, we demonstrated that BP-IgG-induced BP180 internalization is mediated via a macropinocytic pathway. Moreover, a macropinocytosis inhibitor rescued a BP-IgG-induced reduction in the adhesive strength of the cells from their substrate. The results of this study suggest that BP180 internalization induced by BP-IgG plays an important role in the initiation of disease pathogenesis.

SUBMITTER: Hiroyasu S 

PROVIDER: S-EPMC3590760 | biostudies-literature | 2013 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.

Hiroyasu Sho S   Ozawa Toshiyuki T   Kobayashi Hiromi H   Ishii Masamitsu M   Aoyama Yumi Y   Kitajima Yasuo Y   Hashimoto Takashi T   Jones Jonathan C R JC   Tsuruta Daisuke D  

The American journal of pathology 20130119 3


Bullous pemphigoid (BP) is an autoimmune blistering skin disease induced by pathogenic autoantibodies against a type II transmembrane protein (BP180, collagen type XVII, or BPAG2). In animal models, BP180 autoantibody-antigen interaction appears insufficient to develop blisters, but involvement of complement and neutrophils is required. However, cultured keratinocytes treated with BP-IgG exhibit a reduction in the adhesive strength and a loss of expression of BP180, suggesting that the autoantib  ...[more]

Similar Datasets

| S-EPMC5885813 | biostudies-literature
| S-EPMC6379344 | biostudies-literature
| S-EPMC6462259 | biostudies-literature
| S-EPMC6549357 | biostudies-literature
| S-EPMC7138251 | biostudies-literature
| S-EPMC2546607 | biostudies-literature
| S-EPMC8141602 | biostudies-literature
| S-EPMC6455081 | biostudies-literature
| S-EPMC5560122 | biostudies-other